U.S. District Court Invalidates Amgen Patent Claims Targeting PCSK9
Go back to U.S. District Court Invalidates Amgen Patent Claims Targeting PCSK9| Regeneron (NASDAQ: REGN) | Delayed: 762.81 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $762.81 | 52 Week High | $592.36 | |||
| Open | $762.81 | 52 Week Low | $325.35 | |||
| Day High | $762.81 | P/E | 200.21 | |||
| Day Low | $762.81 | EPS | $3.81 | |||
| Volume | 63 | |||||



